The long‐acting β‐adrenoceptor agonist, indacaterol, inhibits IgE‐dependent responses of human lung mast cells

Abstract

Indacaterol is an effective inhibitor of the release of mediators from human lung mast cells. This suggests that, as well as bronchodilation, mast cell stabilization may constitute an additional therapeutic benefit of indacaterol.